Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (14713)
All Articles published online
|
Publishing Process of This Article
|
Aug 7, 2016 (publication date) through Apr 16, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Severson TJ, Besur S, Bonkovsky HL. Genetic factors that affect nonalcoholic fatty liver disease: A systematic clinical review. World J Gastroenterol 2016; 22(29): 6742-6756 [PMID: 27547017 DOI: 10.3748/wjg.v22.i29.6742] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3214/full/v22/i29/6742.htm |
| Number | Citing Articles |
| 1 |
Umar Hayat, Ali A. Siddiqui, Muhammad L. Farhan, Ahmed Haris, Nasir Hameed. Genome Editing in Cardiovascular and Metabolic Diseases. Advances in Experimental Medicine and Biology 2023; 1396: 191 doi: 10.1007/978-981-19-5642-3_13
|
| 2 |
Ming Qiao, Jian-hua Yang, Yi Zhu, Jun-ping Hu. Association of sorting and assembly machinery component 50 homolog gene polymorphisms with nonalcoholic fatty liver disease susceptibility. Medicine 2022; 101(29): e29958 doi: 10.1097/MD.0000000000029958
|
| 3 |
Zheng-Jie Xu, Jun-Ping Shi, De-Rong Yu, Li-Juan Zhu, Ji-Dong Jia, Jian-Gao Fan. Evaluating the Relationship Between Metabolic Syndrome and Liver Biopsy-Proven Non-Alcoholic Steatohepatitis in China: A Multicenter Cross-Sectional Study Design. Advances in Therapy 2016; 33(11): 2069 doi: 10.1007/s12325-016-0416-4
|
| 4 |
Szkup Małgorzata, Brodowski Jacek, Owczarek Aleksander Jerzy, Choręza Piotr, Jurczak Anna, Grochans Elżbieta. Searching for Factors Raising the Incidence of Metabolic Syndrome Among 45-60-Year-Old Women. Aging and disease 2018; 9(5): 831 doi: 10.14336/AD.2017.1027
|
| 5 |
Magnus Holmer, Mattias Ekstedt, Patrik Nasr, Robin Zenlander, Axel Wester, Federica Tavaglione, Stefano Romeo, Stergios Kechagias, Per Stål, Hannes Hagström. Effect of common genetic variants on the risk of cirrhosis in non‐alcoholic fatty liver disease during 20 years of follow‐up. Liver International 2022; 42(12): 2769 doi: 10.1111/liv.15438
|
| 6 |
Teruki Miyake, Yoichi Hiasa. The Evolving Landscape of Liver Cirrhosis Management. 2019; : 1 doi: 10.1007/978-981-13-7979-6_1
|
| 7 |
Ann P. Walker. Ischaemic stroke and liver fibrosis. Atherosclerosis 2017; 260: 153 doi: 10.1016/j.atherosclerosis.2017.03.028
|
| 8 |
Ali Saeed, Robin Dullaart, Tim Schreuder, Hans Blokzijl, Klaas Faber. Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD). Nutrients 2017; 10(1): 29 doi: 10.3390/nu10010029
|
| 9 |
Daniel F. Mazo, Fernanda M. Malta, Jose Tadeu Stefano, Ana Paula M. Salles, Michele S. Gomes-Gouvea, Ana Catharina S. Nastri, Jazon R. Almeida, Joao Renato R. Pinho, Flair J. Carrilho, Claudia P. Oliveira. Validation of PNPLA3 polymorphisms as risk factor for NAFLD and liver fibrosis in an admixed population. Annals of Hepatology 2019; 18(3): 466 doi: 10.1016/j.aohep.2018.10.004
|
| 10 |
T. Herta, J. Fischer, T. Berg. Genetik metabolischer und viraler Lebererkrankungen. Der Gastroenterologe 2017; 12(1): 16 doi: 10.1007/s11377-016-0128-y
|
| 11 |
Fita Nur Jannah, Putri Diyah Anggraini, Abdul Gofur, Sri Rahayu Lestari. The prevention of single bulb garlic extract on non-alcoholic fatty liver disease (NAFLD) in high fat mice (Mus musculus) model. INTERNATIONAL CONFERENCE ON LIFE SCIENCES AND TECHNOLOGY (ICoLiST 2020) 2021; 2353: 030095 doi: 10.1063/5.0052672
|
| 12 |
Manu V. Chakravarthy, Brent A. Neuschwander‐Tetri. The metabolic basis of nonalcoholic steatohepatitis. Endocrinology, Diabetes & Metabolism 2020; 3(4) doi: 10.1002/edm2.112
|
| 13 |
Kareem M Abdelraheem, Nahla N Younis, Mohamed A Shaheen, Sahar E Elswefy, Sousou I Ali. Raspberry ketone improves non-alcoholic fatty liver disease induced in rats by modulating sphingosine kinase/sphingosine-1-phosphate and toll-like receptor 4 pathways. Journal of Pharmacy and Pharmacology 2023; 75(7): 985 doi: 10.1093/jpp/rgad044
|
| 14 |
V. Nathan Subramaniam. Ironing out Steatohepatitis. Annals of Hepatology 2017; 16(1): 8 doi: 10.5604/16652681.1226809
|
| 15 |
Cheng Peng, Alastair G. Stewart, Owen L. Woodman, Rebecca H. Ritchie, Cheng Xue Qin. Non-Alcoholic Steatohepatitis: A Review of Its Mechanism, Models and Medical Treatments. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.603926
|
| 16 |
Ashraf K. Awaad, Maher A. Kamel, Magdy M. Mohamed, Madiha H. Helmy, Magda I. Youssef, Eiman I. Zaki, Marwa M. Essawy, Marwa G. A. Hegazy. The role of hepatic transcription factor cAMP response element-binding protein (CREB) during the development of experimental nonalcoholic fatty liver: a biochemical and histomorphometric study. Egyptian Liver Journal 2020; 10(1) doi: 10.1186/s43066-020-00046-8
|
| 17 |
Gabriel Scarlat, Bassil Dona, Mihai Cârstea, Marilena Stoian. Insights into Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis. Internal Medicine 2022; 19(1): 61 doi: 10.2478/inmed-2022-0198
|
| 18 |
Chaonan Xu, Zhimin Ma, Yunfeng Wang, Xiangtong Liu, Lixin Tao, Deqiang Zheng, Xiuhua Guo, Xinghua Yang. Visceral adiposity index as a predictor of NAFLD: A prospective study with 4‐year follow‐up. Liver International 2018; 38(12): 2294 doi: 10.1111/liv.13941
|
| 19 |
Maddi Oses, Cristina Cadenas‐Sanchez, María Medrano, Arkaitz Galbete, Emiliano Miranda‐Ferrua, Jonatan R. Ruiz, Felix Sánchez‐Valverde, Francisco B. Ortega, Rafael Cabeza, Arantxa Villanueva, Fernando Idoate, Idoia Labayen. Development of a prediction protocol for the screening of metabolic associated fatty liver disease in children with overweight or obesity. Pediatric Obesity 2022; 17(9) doi: 10.1111/ijpo.12917
|
| 20 |
Anna L. Lang, Juliane I. Beier. Interaction of volatile organic compounds and underlying liver disease: a new paradigm for risk. Biological Chemistry 2018; 399(11): 1237 doi: 10.1515/hsz-2017-0324
|
| 21 |
Quelson Coelho Lisboa, Mateus Jorge Nardelli, Patrícia de Araújo Pereira, Débora Marques Miranda, Stephanie Nunes Ribeiro, Raissa Soares Neves Costa, Camila Azevedo Versiani, Paula Vieira Teixeira Vidigal, Teresa Cristina de Abreu Ferrari, Claudia Alves Couto. <i>PNPLA3</i> and <i>TM6SF2 </i>polymorphisms in Brazilian patients with nonalcoholic fatty liver disease. World Journal of Hepatology 2020; 12(10): 792-806 doi: 10.4254/wjh.v12.i10.792
|
| 22 |
Darina Falbová, Lenka Vorobeľová, Daniela Siváková, Radoslav Beňuš. Association between FTO (rs17817449) genetic variant, gamma‐glutamyl transferase, and hypertension in Slovak midlife women. American Journal of Human Biology 2022; 34(4) doi: 10.1002/ajhb.23672
|
| 23 |
Efstathia Thymiakou, Alaa Othman, Thorsten Hornemann, Dimitris Kardassis. Defects in High Density Lipoprotein metabolism and hepatic steatosis in mice with liver-specific ablation of Hepatocyte Nuclear Factor 4A. Metabolism 2020; 110: 154307 doi: 10.1016/j.metabol.2020.154307
|
| 24 |
Sarah E. Kleinstein, Matthew Rein, Manal F. Abdelmalek, Cynthia D. Guy, David B. Goldstein, Anna Mae Diehl, Cynthia A. Moylan. Whole‐Exome Sequencing Study of Extreme Phenotypes of NAFLD. Hepatology Communications 2018; 2(9): 1021 doi: 10.1002/hep4.1227
|
| 25 |
Leanne Hodson, Pippa J. Gunn. The regulation of hepatic fatty acid synthesis and partitioning: the effect of nutritional state. Nature Reviews Endocrinology 2019; 15(12): 689 doi: 10.1038/s41574-019-0256-9
|
| 26 |
Muhammad Imran, Frédéric Chalmel, Odile Sergent, Bertrand Evrard, Hélène Le Mentec, Antoine Legrand, Aurélien Dupont, Maëlle Bescher, Simon Bucher, Bernard Fromenty, Laurence Huc, Lydie Sparfel, Dominique Lagadic-Gossmann, Normand Podechard. Transcriptomic analysis in zebrafish larvae identifies iron-dependent mitochondrial dysfunction as a possible key event of NAFLD progression induced by benzo[a]pyrene/ethanol co-exposure. Cell Biology and Toxicology 2023; 39(2): 371 doi: 10.1007/s10565-022-09706-4
|
| 27 |
Wenpei Liu, Lihuan Lu, Hongqiu Pan, Xiaomin He, Meiling Zhang, Nannan Wang, Jia Zhu, Honggang Yi, Shaowen Tang. Heme oxygenase-1 and hemopexin gene polymorphisms and the risk of anti-tuberculosis drug-induced hepatotoxicity in China. Pharmacogenomics 2022; 23(7): 431 doi: 10.2217/pgs-2022-0015
|
| 28 |
Xiaoyi Xu, Hangfei Xu, Xiaohui Liu, Shuang Zhang, Zhenhuan Cao, Lixia Qiu, Xiaofei Du, Yali Liu, Gang Wang, Li Zhang, Yang Zhang, Jing Zhang. MBOAT7 rs641738 (C>T) is associated with NAFLD progression in men and decreased ASCVD risk in elder Chinese population. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1199429
|
| 29 |
Jose D. Torres-Peña, Laura Martín-Piedra, Francisco Fuentes-Jiménez. Statins in Non-alcoholic Steatohepatitis. Frontiers in Cardiovascular Medicine 2021; 8 doi: 10.3389/fcvm.2021.777131
|
| 30 |
Fajar Dwi Astarini, Neneng Ratnasari, Widya Wasityastuti. Update on Non-Alcoholic Fatty Liver Disease-Associated Single Nucleotide Polymorphisms and Their Involvement in Liver Steatosis, Inflammation, and Fibrosis: A Narrative Review. Iranian Biomedical Journal 2022; 26(4): 252 doi: 10.52547/ibj.3647
|
| 31 |
Ruth Schübel, Tobias Nonnenmacher, Disorn Sookthai, Sandra Gonzalez Maldonado, Solomon Sowah, Oyunbileg von Stackelberg, Christopher Schlett, Mirja Grafetstätter, Diana Nabers, Theron Johnson, Romy Kirsten, Cornelia Ulrich, Rudolf Kaaks, Hans-Ulrich Kauczor, Tilman Kühn, Johanna Nattenmüller. Similar Weight Loss Induces Greater Improvements in Insulin Sensitivity and Liver Function among Individuals with NAFLD Compared to Individuals without NAFLD. Nutrients 2019; 11(3): 544 doi: 10.3390/nu11030544
|
| 32 |
Arthur Ivan N. Oliveira, Fernanda M. Malta, Patricia Momoyo Y. Zitelli, Ana Paula M. Salles, Michele S. Gomes-Gouvea, Ana Catharina S. Nastri, Joao Renato R. Pinho, Flair J. Carrilho, Claudia P. Oliveira, Maria Cássia Mendes-Corrêa, Mario G. Pessoa, Daniel F. Mazo. The role of PNPLA3 and TM6SF2 polymorphisms on liver fibrosis and metabolic abnormalities in Brazilian patients with chronic hepatitis C. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01654-3
|
| 33 |
Fernando Bessone, María Valeria Razori, Marcelo G. Roma. Molecular pathways of nonalcoholic fatty liver disease development and progression. Cellular and Molecular Life Sciences 2019; 76(1): 99 doi: 10.1007/s00018-018-2947-0
|
| 34 |
Renata Risi, Dario Tuccinardi, Stefania Mariani, Carla Lubrano, Silvia Manfrini, Lorenzo Maria Donini, Mikiko Watanabe. Liver disease in obesity and underweight: the two sides of the coin. A narrative review. Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity 2021; 26(7): 2097 doi: 10.1007/s40519-020-01060-w
|
| 35 |
Ludovico Abenavoli, Natasa Milic, Francesco Luzza, Luigi Boccuto, Antonino De Lorenzo. Polyphenols treatment in patients with nonalcoholic fatty liver disease. Journal of Translational Internal Medicine 2017; 5(3): 144 doi: 10.1515/jtim-2017-0027
|
| 36 |
Christopher J. Schmoyer, Mohammad S. Siddiqui. Non-alcoholic Fatty Liver Disease in Non-obese Patients. Current Hepatology Reports 2017; 16(4): 382 doi: 10.1007/s11901-017-0377-3
|
| 37 |
Miaomiao Yang, Haiping Zhang, Bilin Tao, Hongqiu Pan, Lihuan Lu, Honggang Yi, Shaowen Tang. Possible association of HMOX1 and NQO1 polymorphisms with anti-tuberculosis drug-induced liver injury: A matched case-control study. Journal of Clinical Pharmacy and Therapeutics 2019; 44(4): 534 doi: 10.1111/jcpt.12818
|
| 38 |
Rohini Mehta, Kianoush Jeiran, Aaron B. Koenig, Munkzhul Otgonsuren, Zachary Goodman, Ancha Baranova, Zobair Younossi. The role of mitochondrial genomics in patients with non-alcoholic steatohepatitis (NASH). BMC Medical Genetics 2016; 17(1) doi: 10.1186/s12881-016-0324-0
|
| 39 |
Dan L. Longo, Anna M. Diehl, Christopher Day. Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis. New England Journal of Medicine 2017; 377(21): 2063 doi: 10.1056/NEJMra1503519
|
| 40 |
Claudia Phen, Charina M. Ramirez. Hepatic Steatosis in the Pediatric Population: An Overview of Pathophysiology, Genetics, and Diagnostic Workup. Clinical Liver Disease 2021; 17(3): 191 doi: 10.1002/cld.1008
|
| 41 |
Alberto Lopez, Jose Aguilar. A Data Analysis Smart System for the Optimal Deployment of Nanosensors in the Context of an eHealth Application. Algorithms 2023; 16(2): 81 doi: 10.3390/a16020081
|
| 42 |
Giuseppina R Umano, Sonia Caprio, Anna Di Sessa, Naga Chalasani, Daniel J Dykas, Bridget Pierpont, Allen E Bale, Nicola Santoro. The rs626283 Variant in the MBOAT7 Gene is Associated with Insulin Resistance and Fatty Liver in Caucasian Obese Youth. American Journal of Gastroenterology 2018; 113(3): 376 doi: 10.1038/ajg.2018.1
|
| 43 |
Joseph M Pappachan, Shithu Babu, Babu Krishnan, Nishal C Ravindran. Non-alcoholic Fatty Liver Disease: A Clinical Update. Journal of Clinical and Translational Hepatology 2017; (XX): XX doi: 10.14218/JCTH.2017.00013
|
| 44 |
Uijin Kim, Nahyun Kim, Ha Youn Shin. Modeling Non-Alcoholic Fatty Liver Disease (NAFLD) Using “Good-Fit” Genome-Editing Tools. Cells 2020; 9(12): 2572 doi: 10.3390/cells9122572
|
| 45 |
Ligiane Marques Loureiro, Suzane Lessa, Rodrigo Mendes, Sílvia Pereira, Carlos José Saboya, Andrea Ramalho. Does the Metabolically Healthy Obese Phenotype Protect Adults with Class III Obesity from Biochemical Alterations Related to Bone Metabolism?. Nutrients 2019; 11(9): 2125 doi: 10.3390/nu11092125
|
| 46 |
Charlotte J. Green, Siôn A. Parry, Pippa J. Gunn, Carlo D.L. Ceresa, Fredrik Rosqvist, Marie-Eve Piché, Leanne Hodson. Studying non-alcoholic fatty liver disease: the ins and outs of in vivo, ex vivo and in vitro human models. Hormone Molecular Biology and Clinical Investigation 2020; 41(1) doi: 10.1515/hmbci-2018-0038
|
| 47 |
Donglei Sun, Tianhe Zhao, Qian Zhang, Mei Wu, Zunzhen Zhang. Fat mass and obesity‐associated protein regulates lipogenesis via m6A modification in fatty acid synthase mRNA. Cell Biology International 2021; 45(2): 334 doi: 10.1002/cbin.11490
|
| 48 |
Elena Corradini, Elena Buzzetti, Paola Dongiovanni, Stefania Scarlini, Angela Caleffi, Serena Pelusi, Isabella Bernardis, Paolo Ventura, Raffaela Rametta, Elena Tenedini, Enrico Tagliafico, Anna Ludovica Fracanzani, Silvia Fargion, Antonello Pietrangelo, Luca Vittorio Valenti. Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with NAFLD. Journal of Hepatology 2021; 75(3): 506 doi: 10.1016/j.jhep.2021.03.014
|
| 49 |
Zhan Gu, Yan Bi, Fan Yuan, Ruirui Wang, Dong Li, Jianying Wang, Xiaojuan Hu, Guang He, Lei Zhang, Bao-cheng Liu. <p><em>FTO</em> Polymorphisms are Associated with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Susceptibility in the Older Chinese Han Population</p>. Clinical Interventions in Aging 2020; : 1333 doi: 10.2147/CIA.S254740
|
| 50 |
Sixing Shen, Lingyan Pan. Effect of metabolic dysfunction‑associated fatty liver disease on the risk of hepatocellular carcinoma in patients with chronic hepatitis B: A systematic review and meta‑analysis. Experimental and Therapeutic Medicine 2024; 27(3) doi: 10.3892/etm.2024.12387
|
| 51 |
Chiara Compagnoni, Roberta Capelli, Veronica Zelli, Alessandra Corrente, Davide Vecchiotti, Irene Flati, Mauro Di Vito Nolfi, Adriano Angelucci, Edoardo Alesse, Francesca Zazzeroni, Alessandra Tessitore. MiR-182-5p Is Upregulated in Hepatic Tissues from a Diet-Induced NAFLD/NASH/HCC C57BL/6J Mouse Model and Modulates Cyld and Foxo1 Expression. International Journal of Molecular Sciences 2023; 24(11): 9239 doi: 10.3390/ijms24119239
|
| 52 |
Oluwafolajimi Adesanya, Diptatanu Das, Auinash Kalsotra. Emerging roles of RNA‐binding proteins in fatty liver disease. WIREs RNA 2024; 15(2) doi: 10.1002/wrna.1840
|
| 53 |
Yue Feng, Yanlin Li, Wenduo Jiang, Yun Hu, Yimin Jia, Ruqian Zhao. GR-mediated transcriptional regulation of m6A metabolic genes contributes to diet-induced fatty liver in hens. Journal of Animal Science and Biotechnology 2021; 12(1) doi: 10.1186/s40104-021-00642-7
|
| 54 |
Giulia Bellini, Emanuele Miraglia del Giudice, Valerio Nobili, Francesca Rossi. The IRGM rs10065172 variant increases the risk for steatosis but not for liver damage progression in Italian obese children. Journal of Hepatology 2017; 67(3): 653 doi: 10.1016/j.jhep.2017.02.037
|
| 55 |
Navya Malladi, Md Jahangir Alam, Subir K. Maulik, Sanjay K. Banerjee. The role of platelets in non-alcoholic fatty liver disease: From pathophysiology to therapeutics. Prostaglandins & Other Lipid Mediators 2023; 169: 106766 doi: 10.1016/j.prostaglandins.2023.106766
|
| 56 |
Pablo Gabriel-Medina, Roser Ferrer-Costa, Francisco Rodriguez-Frias, Andreea Ciudin, Salvador Augustin, Jesus Rivera-Esteban, Juan M. Pericàs, David Martinez Selva. Influence of Type 2 Diabetes in the Association of PNPLA3 rs738409 and TM6SF2 rs58542926 Polymorphisms in NASH Advanced Liver Fibrosis. Biomedicines 2022; 10(5): 1015 doi: 10.3390/biomedicines10051015
|
| 57 |
Omar E. Hegazi, Samer O. Alalalmeh, Ghala Rashid Humaid Alnuaimi, Moyad Shahwan, Ammar Abdulrahman Jairoun, Nasser M. Alorfi, Shaker A. Majrashi, Mustfa Faisal Alkhanani, Abdullah Alkhattabi, Mansour M. Alourfi, Faris A. Alsolami, Saeed Alsharif, Hatim Alshahrani. NAFLD and nutraceuticals: a review of completed phase III and IV clinical trials. Frontiers in Medicine 2023; 10 doi: 10.3389/fmed.2023.1227046
|
| 58 |
Jose D. Torres-Peña, Antonio P. Arenas-de Larriva, Juan F. Alcala-Diaz, Jose Lopez-Miranda, Javier Delgado-Lista. Different Dietary Approaches, Non-Alcoholic Fatty Liver Disease and Cardiovascular Disease: A Literature Review. Nutrients 2023; 15(6): 1483 doi: 10.3390/nu15061483
|
| 59 |
Herbert L. Bonkovsky, Tyler Severson, Paola Nicoletti, Huiman Barnhart, Jose Serrano, Naga Chalasani, Robert J. Fontana, Paul B. Watkins, Victor Navarro, Andrew Stolz, Ann K. Daly, Guruparasad P. Aithal, Joseph Odin. Genetic Polymorphisms Implicated in Nonalcoholic Liver Disease or Selected Other Disorders Have No Influence on Drug‐Induced Liver Injury. Hepatology Communications 2019; 3(8): 1032 doi: 10.1002/hep4.1382
|
| 60 |
Somaya Albhaisi, Arun J. Sanyal. Gene-Environmental Interactions as Metabolic Drivers of Nonalcoholic Steatohepatitis. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.665987
|
| 61 |
Kuniko Yamamoto, Tomomi Kogiso, Makiko Taniai, Etsuko Hashimoto, Katsutoshi Tokushige. Differences in the genetic backgrounds of patients with alcoholic liver disease and non‐alcoholic fatty liver disease. JGH Open 2019; 3(1): 17 doi: 10.1002/jgh3.12097
|
| 62 |
Casimiro Castillejo-López, José Ramón Bárcenas-Walls, Marco Cavalli, Anders Larsson, Claes Wadelius. A regulatory element associated to NAFLD in the promoter of DIO1 controls LDL-C, HDL-C and triglycerides in hepatic cells. Lipids in Health and Disease 2024; 23(1) doi: 10.1186/s12944-024-02029-9
|
| 63 |
Joseph Boachie, Antonysunil Adaikalakoteswari, Jinous Samavat, Ponnusamy Saravanan. Low Vitamin B12 and Lipid Metabolism: Evidence from Pre-Clinical and Clinical Studies. Nutrients 2020; 12(7): 1925 doi: 10.3390/nu12071925
|
| 64 |
Luis Antonio Díaz, Marcela Villota-Rivas, Francisco Barrera, Jeffrey V. Lazarus, Marco Arrese. The burden of liver disease in Latin America. Annals of Hepatology 2023; : 101175 doi: 10.1016/j.aohep.2023.101175
|
| 65 |
Haleh Chehrehgosha, Masoud Reza Sohrabi, Faramarz Ismail-Beigi, Mojtaba Malek, Mohammad Reza Babaei, Farhad Zamani, Hossein Ajdarkosh, Mahmood Khoonsari, Afshin Eshghi Fallah, Mohammad E. Khamseh. Empagliflozin Improves Liver Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Diabetes Therapy 2021; 12(3): 843 doi: 10.1007/s13300-021-01011-3
|
| 66 |
Sana Raza, Archana Tewari, Sangam Rajak, Rohit A. Sinha. Vitamins and non-alcoholic fatty liver disease: A molecular insight. Liver Research 2021; 5(2): 62 doi: 10.1016/j.livres.2021.03.004
|
| 67 |
Maria Notarnicola, Alberto Ruben Osella, Maria Gabriella Caruso, Pasqua Letizia Pesole, Antonio Lippolis, Valeria Tutino, Caterina Bonfiglio, Valentina De Nunzio, Maria Principia Scavo, Antonella Mirizzi, Isabella Franco, Tamara Lippolis, Rosalba D’Alessandro, Maria Grazia Refolo, Caterina Messa. Nonalcoholic Fatty Liver Disease: Focus on New Biomarkers and Lifestyle Interventions. International Journal of Molecular Sciences 2021; 22(8): 3899 doi: 10.3390/ijms22083899
|
| 68 |
Amedeo Lonardo, Fabio Nascimbeni, Mauro Maurantonio, Alessandra Marrazzo, Luca Rinaldi, Luigi Elio Adinolfi. Nonalcoholic fatty liver disease: Evolving paradigms. World Journal of Gastroenterology 2017; 23(36): 6571-6592 doi: 10.3748/wjg.v23.i36.6571
|
| 69 |
Antonina Kedyk, Oleksandr Kutsyn. Metabolic effects of empagliflozine. Diabetes Obesity Metabolic Syndrome 2022; (5): 38 doi: 10.57105/2415-7252-2022-5-04
|
| 70 |
Luma Melo, Merve Bilici, Amit Hagar, James E. Klaunig. The effect of endurance training on non‐alcoholic fatty liver disease in mice. Physiological Reports 2021; 9(15) doi: 10.14814/phy2.14926
|
| 71 |
Qun Liu, Shou-Sheng Liu, Zhen-Zhen Zhao, Ben-Tian Zhao, Shui-Xian Du, Wen-Wen Jin, Yong-Ning Xin. TRIB1 rs17321515 gene polymorphism increases the risk of coronary heart disease in general population and non-alcoholic fatty liver disease patients in Chinese Han population. Lipids in Health and Disease 2019; 18(1) doi: 10.1186/s12944-019-1108-2
|